IL253497B2
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| US2011263828A1 | Cites | United States of America | Y | Search report | 1-19 |
| WO2013120066A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-19 |
| LOU, YI-WEI, ET AL., STAGE-SPECIFIC EMBRYONIC ANTIGEN-4 AS A POTENTIAL THERAPEUTIC TARGET IN GLIOBLASTOMA MULTIFORME AND OTHER CANCERS., 18 February 2014 (2014-02-18) | Non-patent | – | – | Search report | – |
| HUANG, WEI, ET AL., CHEMOENZYMATIC GLYCOENGINEERING OF INTACT IGG ANTIBODIES FOR GAIN OF FUNCTIONS., 16 July 2012 (2012-07-16) | Non-patent | – | – | Search report | – |
235 members in 13 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 201562110338 | United States of America | P | |
| 201514723297 | United States of America | A | |
| 201514798312 | United States of America | A | |
| 2016015858 | United States of America | W |
Members235
| Document | Office | Kind | |
|---|---|---|---|
| CA2937123A1 | Canada | A1 | |
| WO2015109180A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2015109180A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2950415A1 | Canada | A1 | |
| CA2950423A1 | Canada | A1 | |
| CA2950433A1 | Canada | A1 | |
| CA2950440A1 | Canada | A1 | |
| CA2950577A1 | Canada | A1 | |
| US2015344544A1 | United States of America | A1 | |
| US2015344551A1 | United States of America | A1 | |
| US2015344559A1 | United States of America | A1 | |
| US2015344585A1 | United States of America | A1 | |
| US2015344587A1 | United States of America | A1 | |
| WO2015184001A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2015184002A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2015184004A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2015184008A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2015184009A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2016017390A1 | United States of America | A1 | |
| TW201609135A | Taiwan Province of China | A | |
| TW201609136A | Taiwan Province of China | A | |
| TW201609137A | Taiwan Province of China | A | |
| US2016102151A1 | United States of America | A1 | |
| TW201613970A | Taiwan Province of China | A | |
| TW201614068A | Taiwan Province of China | A | |
| TW201620939A | Taiwan Province of China | A | |
| AU2015206370A1 | Australia | A1 | |
| CA2972067A1 | Canada | A1 | |
| WO2016114819A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CA2972072A1 | Canada | A1 | |
| CA2972731A1 | Canada | A1 | |
| US2016213763A1 | United States of America | A1 | |
| WO2016118191A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2016118961A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201626999A | Taiwan Province of China | A | |
| TW201627324A | Taiwan Province of China | A | |
| CA2973886A1 | Canada | A1 | |
| WO2016123591A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2016123593A1 | World Intellectual Property Organization (WIPO) | A1 | |
| IL246707A0 | Israel | A0 | |
| IL246707D0 | Israel | D0 | |
| KR20160104727A | Republic of Korea | A | |
| US2016274121A1 | United States of America | A1 | |
| US2016280794A1 | United States of America | A1 | |
| US2016289340A1 | United States of America | A1 | |
| TW201636363A | Taiwan Province of China | A | |
| EP3094352A2 | European Patent Office (EPO) | A2 | |
| AU2015267044A1 | Australia | A1 | |
| AU2015267052A1 | Australia | A1 | |
| WO2016123591A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2015267045A1 | Australia | A1 | |
| AU2015267047A1 | Australia | A1 | |
| KR20170003720A | Republic of Korea | A | |
| KR20170004023A | Republic of Korea | A | |
| KR20170004024A | Republic of Korea | A | |
| KR20170005142A | Republic of Korea | A | |
| AU2015267051A1 | Australia | A1 | |
| TW201702268A | Taiwan Province of China | A | |
| TW201702269A | Taiwan Province of China | A | |
| KR20170010003A | Republic of Korea | A | |
| IL249183A0 | Israel | A0 | |
| IL249183D0 | Israel | D0 | |
| IL249184A0 | Israel | A0 | |
| IL249184D0 | Israel | D0 | |
| IL249186A0 | Israel | A0 | |
| IL249186D0 | Israel | D0 | |
| IL249188A0 | Israel | A0 | |
| IL249188D0 | Israel | D0 | |
| IL249195A0 | Israel | A0 | |
| IL249195D0 | Israel | D0 | |
| CN106459920A | China | A | |
| JP2017507118A | Japan | A | |
| EP3149036A1 | European Patent Office (EPO) | A1 | |
| EP3149037A1 | European Patent Office (EPO) | A1 | |
| EP3149045A1 | European Patent Office (EPO) | A1 | |
| EP3149161A1 | European Patent Office (EPO) | A1 | |
| CN106573971A | China | A | |
| EP3154582A1 | European Patent Office (EPO) | A1 | |
| CN106661099A | China | A | |
| CN106661562A | China | A | |
| CN106714829A | China | A | |
| US2017168716A1 | United States of America | A1 | |
| WO2017100796A1 | World Intellectual Property Organization (WIPO) | A1 | |
| JP2017517518A | Japan | A | |
| AU2015377230A1 | Australia | A1 | |
| AU2015378564A1 | Australia | A1 | |
| JP2017518989A | Japan | A | |
| JP2017518990A | Japan | A | |
| AU2016209056A1 | Australia | A1 | |
| JP2017520241A | Japan | A | |
| AU2016211176A1 | Australia | A1 | |
| JP2017523131A | Japan | A | |
| CN107074945A | China | A | |
| KR20170098954A | Republic of Korea | A | |
| IL253160A0 | Israel | A0 | |
| IL253160D0 | Israel | D0 | |
| IL253161A0 | Israel | A0 | |
| IL253161D0 | Israel | D0 | |
| IL253162A0 | Israel | A0 | |
| IL253162D0 | Israel | D0 |
Showing 100 of 235
Numbers
- Publication
- 253497
- Application
- 253497
Titles2
- English
- Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
- Hebrew
- תכשירים ושיטות קשורים לגליקופורמים אוניברסליים עבור יעילות נוגדן משופרת
Classification
- CPC, 17
- C07K16/18
- C07K16/32
- C07K16/44
- A61P35/00
- C07K2317/732
- C07K2317/622
- C07K2317/41
- C07K2317/72
- C07K2317/92
- C07K2317/734
- C07K2317/56
- C07K2317/565
- C07K2317/24
- A61K2039/505
- C07K16/241
- C07K16/2887
- C07K16/3084
- IPC, 4
- C07K16 18
- C07K16 24
- C07K16 28
- C07K16 32